Jyoti G Mannari, Geeta Kanjariya, Maulin K Shah, Chirag Modi, Jaishree Ganjiwale
{"title":"尿培养和抗生素敏感性对改善临床医生治疗尿路感染选择的重要性。","authors":"Jyoti G Mannari, Geeta Kanjariya, Maulin K Shah, Chirag Modi, Jaishree Ganjiwale","doi":"10.59556/japi.72.0783","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The local antibiogram is essential to prevent the development of multidrug-resistant organisms. The aim of the study was to find out the synchronization of empirical antibiotics with the sensitivity pattern of the urine culture report and to study the differences in the organisms and sensitivity patterns in urinary tract infection (UTI) with and without other comorbidities.</p><p><strong>Materials and methods: </strong>UTI, diagnosed by a positive urine culture report of 300 consecutive patients above the age of 18, was studied retrospectively. The data were processed using the statistical software STATA 14.</p><p><strong>Results: </strong>Out of 300 patients, 58.3% were females. The mean [standard deviation (SD)] age was 54.19 (19.06) years. The most common associated comorbidity was diabetes mellitus (DM) (34.7%). Lower urinary tract symptoms (LUTS) were the most common presenting symptom, followed by dysuria and fever. The most common organism was <i>Escherichia coli</i> in both nondiabetic and diabetic patients (67.3% and 60.6%). Comparing diabetics and nondiabetics, recurrent UTI (15.4 vs 5.1%), infection with extended-spectrum beta-lactamase (ESBL) organisms (67.3 vs 51.5%), and prolonged hospitalization (75 vs 61.2%) were observed more in diabetics. The most common empirical antibiotic chosen was cefoperazone-sulbactam in the diabetic group and levofloxacin in the nondiabetic group. Empirical antibiotics in diabetics matched with the sensitivity in 57.1% of ESBL cases and 47% of non-ESBL cases, while in nondiabetics, this alignment was 40.5% in ESBL cases and 61% in non-ESBL cases. Resistance to oral fluoroquinolone, cotrimoxazole, and nitrofurantoin was 78, 59.3, and 39.6%, respectively, while resistance to meropenem and amikacin was 35.6 and 25.6%.</p><p><strong>Conclusion: </strong>The increasing prevalence of ESBL-positive strains and rising resistance to common antimicrobial drugs raise concerns for future therapeutic options.</p>","PeriodicalId":22693,"journal":{"name":"The Journal of the Association of Physicians of India","volume":"72 12","pages":"e30-e34"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Importance of Urine Culture and Antibiotic Sensitivity for Improving Clinicians' Choice in Treating Urinary Tract Infections.\",\"authors\":\"Jyoti G Mannari, Geeta Kanjariya, Maulin K Shah, Chirag Modi, Jaishree Ganjiwale\",\"doi\":\"10.59556/japi.72.0783\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The local antibiogram is essential to prevent the development of multidrug-resistant organisms. The aim of the study was to find out the synchronization of empirical antibiotics with the sensitivity pattern of the urine culture report and to study the differences in the organisms and sensitivity patterns in urinary tract infection (UTI) with and without other comorbidities.</p><p><strong>Materials and methods: </strong>UTI, diagnosed by a positive urine culture report of 300 consecutive patients above the age of 18, was studied retrospectively. The data were processed using the statistical software STATA 14.</p><p><strong>Results: </strong>Out of 300 patients, 58.3% were females. The mean [standard deviation (SD)] age was 54.19 (19.06) years. The most common associated comorbidity was diabetes mellitus (DM) (34.7%). Lower urinary tract symptoms (LUTS) were the most common presenting symptom, followed by dysuria and fever. The most common organism was <i>Escherichia coli</i> in both nondiabetic and diabetic patients (67.3% and 60.6%). Comparing diabetics and nondiabetics, recurrent UTI (15.4 vs 5.1%), infection with extended-spectrum beta-lactamase (ESBL) organisms (67.3 vs 51.5%), and prolonged hospitalization (75 vs 61.2%) were observed more in diabetics. The most common empirical antibiotic chosen was cefoperazone-sulbactam in the diabetic group and levofloxacin in the nondiabetic group. Empirical antibiotics in diabetics matched with the sensitivity in 57.1% of ESBL cases and 47% of non-ESBL cases, while in nondiabetics, this alignment was 40.5% in ESBL cases and 61% in non-ESBL cases. Resistance to oral fluoroquinolone, cotrimoxazole, and nitrofurantoin was 78, 59.3, and 39.6%, respectively, while resistance to meropenem and amikacin was 35.6 and 25.6%.</p><p><strong>Conclusion: </strong>The increasing prevalence of ESBL-positive strains and rising resistance to common antimicrobial drugs raise concerns for future therapeutic options.</p>\",\"PeriodicalId\":22693,\"journal\":{\"name\":\"The Journal of the Association of Physicians of India\",\"volume\":\"72 12\",\"pages\":\"e30-e34\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Journal of the Association of Physicians of India\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.59556/japi.72.0783\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of the Association of Physicians of India","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.59556/japi.72.0783","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
摘要
背景:局部抗生素谱对预防多重耐药菌的发展至关重要。本研究的目的是找出经验性抗生素与尿培养报告的敏感性模式的同步性,并研究有无其他合并症的尿路感染(UTI)的微生物和敏感性模式的差异。材料与方法:回顾性研究连续300例18岁以上患者尿培养阳性诊断的尿路感染。使用统计软件STATA 14对数据进行处理。结果:300例患者中,女性占58.3%。平均[标准差(SD)]年龄为54.19(19.06)岁。最常见的合并症是糖尿病(DM)(34.7%)。下尿路症状(LUTS)是最常见的症状,其次是排尿困难和发烧。非糖尿病和糖尿病患者中最常见的细菌是大肠杆菌(67.3%和60.6%)。与非糖尿病患者相比,糖尿病患者复发性尿路感染(15.4 vs 5.1%)、广谱β -内酰胺酶(ESBL)感染(67.3 vs 51.5%)和延长住院时间(75 vs 61.2%)更多。糖尿病组最常用的经验性抗生素是头孢哌酮舒巴坦,非糖尿病组最常用的是左氧氟沙星。在糖尿病患者中,57.1%的ESBL病例和47%的非ESBL病例与经验抗生素的敏感性相匹配,而在非糖尿病患者中,这一一致性在ESBL病例中为40.5%,在非ESBL病例中为61%。口服氟喹诺酮、复方新诺明和呋喃妥英的耐药率分别为78.3%、59.3%和39.6%,对美罗培南和阿米卡星的耐药率分别为35.6%和25.6%。结论:esbl阳性菌株的流行率不断上升,对常用抗菌药物的耐药性不断上升,这引起了人们对未来治疗方案的关注。
Importance of Urine Culture and Antibiotic Sensitivity for Improving Clinicians' Choice in Treating Urinary Tract Infections.
Background: The local antibiogram is essential to prevent the development of multidrug-resistant organisms. The aim of the study was to find out the synchronization of empirical antibiotics with the sensitivity pattern of the urine culture report and to study the differences in the organisms and sensitivity patterns in urinary tract infection (UTI) with and without other comorbidities.
Materials and methods: UTI, diagnosed by a positive urine culture report of 300 consecutive patients above the age of 18, was studied retrospectively. The data were processed using the statistical software STATA 14.
Results: Out of 300 patients, 58.3% were females. The mean [standard deviation (SD)] age was 54.19 (19.06) years. The most common associated comorbidity was diabetes mellitus (DM) (34.7%). Lower urinary tract symptoms (LUTS) were the most common presenting symptom, followed by dysuria and fever. The most common organism was Escherichia coli in both nondiabetic and diabetic patients (67.3% and 60.6%). Comparing diabetics and nondiabetics, recurrent UTI (15.4 vs 5.1%), infection with extended-spectrum beta-lactamase (ESBL) organisms (67.3 vs 51.5%), and prolonged hospitalization (75 vs 61.2%) were observed more in diabetics. The most common empirical antibiotic chosen was cefoperazone-sulbactam in the diabetic group and levofloxacin in the nondiabetic group. Empirical antibiotics in diabetics matched with the sensitivity in 57.1% of ESBL cases and 47% of non-ESBL cases, while in nondiabetics, this alignment was 40.5% in ESBL cases and 61% in non-ESBL cases. Resistance to oral fluoroquinolone, cotrimoxazole, and nitrofurantoin was 78, 59.3, and 39.6%, respectively, while resistance to meropenem and amikacin was 35.6 and 25.6%.
Conclusion: The increasing prevalence of ESBL-positive strains and rising resistance to common antimicrobial drugs raise concerns for future therapeutic options.